COBTH in the News

“We have an entire 18 months’ worth of small children who have no immunity,” said Dr. Kristin Moffitt, a pediatric infectious diseases specialist at Boston Children’s Hospital.

“People with rheumatic disease are at increased risk of infection due to immune dysregulation and the use of immunosuppressive medications,” Jonathan S. Hausmann, MD, of Beth Israel Deaconess Medical Center, in Boston, and colleagues wrote.

While most of the world has adapted to “virtual” medicine during the pandemic, it is nothing new for some patients at Brigham and Women’s Hospital and Dana-Farber Cancer Institute.

Jessica Malaty Rivera, an infectious disease epidemiologist and research fellow at Boston Children’s Hospital joins to discuss the potential risks posed by the Delta variant.

Landmark Bio will partner with several Harvard Medical School affiliates, including Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, the Dana Farber Cancer Institute, and Massachusetts General Hospital.

CureDuchenne has teamed up with Brigham and Women’s Hospital, in Boston, to launch the nation’s first free newborn screening initiative for Duchenne muscular dystrophy (DMD).